679 related articles for article (PubMed ID: 33239054)
1. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
2. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
3. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
4. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.
Brinton LA; Schwartz L; Spitz MR; Park Y; Hollenbeck AR; Gierach GL
Cancer Causes Control; 2012 Mar; 23(3):487-96. PubMed ID: 22367699
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.
Brinton LA; Richesson D; Leitzmann MF; Gierach GL; Schatzkin A; Mouw T; Hollenbeck AR; Lacey JV
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3150-60. PubMed ID: 18990757
[TBL] [Abstract][Full Text] [Related]
6. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
7. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
8. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
9. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.
Weng CH; Okawa ER; Roberts MB; Park SK; Umbricht CB; Manson JE; Eaton CB
Thyroid; 2020 Apr; 30(4):519-530. PubMed ID: 31918623
[No Abstract] [Full Text] [Related]
11. Changing concepts: Menopausal hormone therapy and breast cancer.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
[TBL] [Abstract][Full Text] [Related]
12. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
Fournier A; Fabre A; Mesrine S; Boutron-Ruault MC; Berrino F; Clavel-Chapelon F
J Clin Oncol; 2008 Mar; 26(8):1260-8. PubMed ID: 18323549
[TBL] [Abstract][Full Text] [Related]
13. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
14. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.
Lew JQ; Freedman ND; Leitzmann MF; Brinton LA; Hoover RN; Hollenbeck AR; Schatzkin A; Park Y
Am J Epidemiol; 2009 Aug; 170(3):308-17. PubMed ID: 19541857
[TBL] [Abstract][Full Text] [Related]
15. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
Lovett SM; Sandler DP; O'Brien KM
J Natl Cancer Inst; 2023 Jun; 115(6):662-670. PubMed ID: 36806439
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
19. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
20. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
